Antoine Hollebecque

机构：Institut Gustave Roussy, Université de Lorraine · ORCID：0000-0003-2869-7551

发表论文 999 篇 · 总被引 27719 次 · h-index 67

代表论文

• Efficacy and safety of lirafugratinib in FGFRi -naïve cholangiocarcinoma (CCA) patients harboring FGFR2 fusions/rearrangements ( FGFR2 f/r). (2026 · Journal of Clinical Oncology · 被引 3)
• Collective cell migration plasticity in patient-derived digestive cancer organoids is dictated by environment sensing and contractility (2026 · Cell Reports · 被引 1)
• Integrated inference of cancer gene expression from cell-free plasma chromatin (2026 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 1)
• Phase 1 evaluation of ASP3082, a first-in-class selective protein degrader, in patients (pts) with KRAS G12D -mutant pancreatic ductal adenocarcinoma (PDAC): Pharmacokinetics (PK) and biomarker insights. (2026 · Journal of Clinical Oncology · 被引 1)
• Continued zenocutuzumab treatment beyond progression in patients with NRG1+ pancreatic cancer and cholangiocarcinoma: Analysis from the phase 2 eNRGy trial. (2026 · Journal of Clinical Oncology · 被引 1)
• The Role of Computed Tomography-Determined Total Tumor Volume at Baseline in Predicting Outcomes of Patients with Locally Advanced Unresectable or Metastatic Pancreatic Ductal Adenocarcinoma (2025 · Cancers · 被引 1)